112326 ⎘
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES having multiple IRES
REPLICATION-DEFECTIVE ARENAVIRUS VECTORS
#2MULTIPLEX ASSAY
#3NOVEL IMMUNOSTIMULATING VECTOR SYSTEM
#4CO-EXPRESSION OF CONSTRUCTS AND IMMUNOINHIBITORY COMPOUNDS
#5Highly Attenuated Replication-Competent Recombinant Poxvirus As A Vaccine Platform And Methods Of Use
#6IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#7Replication-defective arenavirus vectors
#8Genetically Engineered Cells and Uses Thereof
#9COMPOSITIONS AND METHODS FOR TREATING CANCER
#10CIRCULARIZED ENGINEERED RNA AND METHODS
#11Immunostimulating vector system
#12GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA
#13Replication-defective arenavirus vectors
#14Expressed Barcode Libraries and Uses Thereof
#15Generation of human iPS cells by a synthetic self-replicative RNA
#16CMV vaccines
#17Replication-defective arenavirus vectors
#18Immunostimulating vector system
#19METHODS FOR THE PRODUCTION OF IPS CELLS USING NON-VIRAL APPROACH
#20Engineered Cells Expressing Multiple Immunomodulators and Uses Thereof
#21Generation of human iPS cells by a synthetic self-replicative RNA
#22Compositions and methods for treating cancer
#23Animal models, cell lines and methods for screening hepatitis C virus vaccines
#24CMV vaccines
#25Replication-defective arenavirus vectors
#26Stringent selectable markers
#27Generation of human iPS cells by a synthetic self-replicative RNA
#28Replication-defective arenavirus vectors
#29Methods for the production of IPS cells using non-viral approach
#30Methods for the production of IPS cells using Epstein-Barr (EBV)-based reprogramming vectors
#31IRES mediated multicistronic vectors
#32Stringent selectable markers
#33Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same
#34Selection of host cells expressing protein at high levels
#35Method
#36Engineered cells expressing multiple immunomodulators and uses thereof
#37VECTORS AND METHODS FOR GENERATING VECTOR-FREE INDUCED PLURIPOTENT STEM (IPS) CELLS USING SITE-SPECIFIC RECOMBINATION
#38Adenoviruses, nucleic acids that code for the same and the use of said viruses
#39Replication-defective arenavirus vectors
#40Eukaryotic layered vector initiation systems
#41HCV NS3 protease replicon shuttle vectors
#42Methods for the production of iPS cells using non-viral approach
#43Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines
#44Reprogramming of Differentiated Progenitor or Somatic Cells Using Homologous Recombination
#45Vector System
#46HCV NS3 replicon shuttle vectors
#47Vectors having both isoforms of beta-hexosaminidase and uses of the same
#48Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
#49Expression Vectors and Methods
#50Expression Vectors and Methods
#51Vector system
#52Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
#53Multi-cistronic vectors for gene transfer protocols
#54Self-replicating RNA molecule from hepatitis C virus
#55Selection of host cells expressing protein at high levels
#56Alphavirus replicon vector systems
#57Viral vectors and the use of the same for gene therapy
#58Selection of host cells expressing protein at high levels
#59Directed genetic modifications of human stem cells
#60Modified dendritic cells
#61Vectors having both isoforms of beta-hexosaminidase
#62Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
#63Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
#64Methods of preforming homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof
#65Expression vectors and methods
#66Vector system
#67System and process for in vivo manufacturing nanostructure-ended double-stranded covalently-closed linear DNA, the resulting molecules and their uses